Literature DB >> 2724718

Detection of androgen receptors in human esophageal cancer.

Y Yamashita1, T Hirai, H Mukaida, K Kawano, T Toge, M Niimoto, T Hattori.   

Abstract

The incidence of esophageal cancer is much higher in men than in women and the prognosis is generally worse in men than in women. This seems to depend on the difference in the hormonal environments of the patient. In this paper, androgen receptors (AR) were measured in 21 cases of human esophageal cancer. Of these, two cases of esophageal cancer xenografts implanted into nude mice were AR positive. In EH-1, an established cell line from human esophageal cancer, the number of binding sites was increased and tumor growth was enhanced by testosterone administration. On the other hand, the number of binding sites was decreased and tumor growth was suppressed by castration. The administration of estrogen, however, did not inhibit tumor growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2724718     DOI: 10.1007/bf02471585

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  26 in total

1.  Guide lines for the clinical and pathologic studies on carcinoma of the esophagus.

Authors: 
Journal:  Jpn J Surg       Date:  1976-06

Review 2.  Human prostate steroid hormone receptor quantitation. Current methodology and possible utility as a clinical discriminant in carcinoma.

Authors:  S A Shain; R W Boesel
Journal:  Invest Urol       Date:  1978-11

3.  Effect of sodium molybdate on cytosolic androgen receptors in rat prostate.

Authors:  C M Gaubert; R R Tremblay; J Y Dubé
Journal:  J Steroid Biochem       Date:  1980-08       Impact factor: 4.292

4.  The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy.

Authors:  B Greenway; D Duke; B Pym; M J Iqbal; P J Johnson; R Williams
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

5.  Carcinoma of the esophagus: results of treatment.

Authors:  J G van Andel; J Dees; C M Dijkhuis; W Fokkens; H van Houten; P C de Jong; W M van Woerkom-Eykenboom
Journal:  Ann Surg       Date:  1979-12       Impact factor: 12.969

6.  Estrogen receptors in hepatocellular carcinoma.

Authors:  N Nagasue; A Ito; H Yukaya; Y Ogawa
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

7.  Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors:  G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Hepatomas: hormone receptors and therapy.

Authors:  M A Friedman; D J Demanes; P G Hoffman
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965

9.  Effects of steroid hormone therapy on primarily xenotransplanted human colorectal adenocarcinomas.

Authors:  J R Izbicki; R Schmitz; H O Hoppen; W Izbicki; H Troidl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

10.  Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.

Authors:  M Snochowski; A Pousette; P Ekman; D Bression; L Andersson; B Högberg; J A Gustafsson
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

View more
  7 in total

1.  Androgen receptor promotes esophageal cancer cell migration and proliferation via matrix metalloproteinase 2.

Authors:  Yi Zhang; Tiecheng Pan; Xiaoxuan Zhong; Cai Cheng
Journal:  Tumour Biol       Date:  2015-02-28

Review 2.  Androgens and esophageal cancer: What do we know?

Authors:  Olga A Sukocheva; Bin Li; Steven L Due; Damian J Hussey; David I Watson
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

3.  A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma.

Authors:  S Tanaka; H Ueo; K Mafune; M Mori; J R Wands; K Sugimachi
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

Review 4.  Probing the link between oestrogen receptors and oesophageal cancer.

Authors:  Farhan Rashid; Raheela N Khan; Syed Y Iftikhar
Journal:  World J Surg Oncol       Date:  2010-02-10       Impact factor: 2.754

5.  Genetic variants in sex hormone metabolic pathway genes and risk of esophageal squamous cell carcinoma.

Authors:  Paula L Hyland; Neal D Freedman; Nan Hu; Ze-Zhong Tang; Lemin Wang; Chaoyu Wang; Ti Ding; Jin-Hu Fan; You-Lin Qiao; Asieh Golozar; William Wheeler; Kai Yu; Jeff Yuenger; Laurie Burdett; Stephen J Chanock; Sanford M Dawsey; Margaret A Tucker; Alisa M Goldstein; Christian C Abnet; Philip R Taylor
Journal:  Carcinogenesis       Date:  2013-01-28       Impact factor: 4.944

6.  Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma.

Authors:  Masanori Ikeda; Shoji Natsugoe; Shinichi Ueno; Masamichi Baba; Takashi Aikou
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

7.  Influence of sex on the survival of patients with esophageal cancer.

Authors:  Pierre Bohanes; Dongyun Yang; Ruchika S Chhibar; Melissa J Labonte; Thomas Winder; Yan Ning; Armin Gerger; Léonor Benhaim; David Paez; Takeru Wakatsuki; Fotios Loupakis; Rita El-Khoueiry; Wu Zhang; Heinz-Josef Lenz
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.